Fluid and powder extract from Commiphora myrrha gummi-resin with high content of furanodienes
KEY ACTIONS
RAW MATERIAL
CHARACTERISTIC MOLECULES
ACTION
The bioactive molecules contained in myrrh resin interact with opioid receptors in the central nervous system, activating an analgesic-like actionto counteract common pain symptoms.
Furanodienes have the property of acting as opioid receptor agonists, without triggering the common adverseeffects associated with the consumption of molecules capable of activating this receptors family.
RAW MATERIAL
Myrrh
Commiphora myrrha Engl. Commiphora myrrha Engl. is a thorny tree belonging to the Burseraceae family. It is mainly found in north-eastern Africa, southern Arabia, Latin America and India.
The gummi-resin obtained from the trunk has been known since ancient times for its balsamic and healing properties; it was used in natural medicine for its renowned analgesic, antiseptic and anesthetic properties.
Myrrh
Commiphora myrrha Engl. Commiphora myrrha Engl. is a thorny tree belonging to the Burseraceae family. It is mainly found in north-eastern Africa, southern Arabia, Latin America and India.
The gummi-resin obtained from the trunk has been known since ancient times for its balsamic and healing properties; it was used in natural medicine for its renowned analgesic, antiseptic and anesthetic properties.
FORMULATIONS
MyrLiq® is available in:
- POWDER FORMULATION
- FLUID FORMULATION
Chemical characterisation is based on gas chromatography combined with mass spectrometry (GC-MS) and flame ionisation detector (GC-FID).
MyrLiq® is standardised and titrated at 4% w/w in total furanodienes; this allows accurate dosing in various galenic and nutraceutical forms.
INSIGHTS
MORE ABOUT MyrLiq®
